Skip to content

Protocol of a prospective multi-center randomized controlled clinical trial for the efficacy and safety of estradiol gel for endometrial repair after induced abortion

Protocol of a prospective multi-center randomized controlled clinical trial for the efficacy and safety of estradiol gel for endometrial repair after induced abortion

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053565
Enrollment
Unknown
Registered
2021-11-24
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

artificial abortion

Interventions

experimental group:estradiol gel
control group:Estradiol Gel simulant

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 and = 2 times or missed abortion; 4. The verified true gestational age is less than or equal to 10 weeks, and within three days before operation, the ultrasound shows that the fetal sac (average of three diameters) is more than or equal to >= 1.0cm, and the embryo bud is less than or equal to <= 3.0cm; 5. Preoperative examination is normal according to Clinical Diagnosis and Treatment Guidelines and Technical Operation Specifications: Family Planning Volume (2017 Revision); 6. Be able to follow up regularly and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Contraindications to estrogen; 2. There was a history of intrauterine adhesions or intrauterine operation or correction of uterine malformation confirmed by hysteroscopy; 3. Subjects who are required to place intrauterine devices, oral contraceptives and subcutaneous implants after operation; 4. Those with abnormal mental state and cognitive function who can't cooperate with the treatment process; 5. The researcher thinks that the subject has potential risks or any other factors that interfere with the subject.

Design outcomes

Primary

MeasureTime frame
Endometrial thickness;

Secondary

MeasureTime frame
Hemodynamic level of uterine spiral artery;

Countries

China

Contacts

Public ContactLiu xinyan

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

liuxymeng@163.com+86 18600008013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026